Displaying 141 - 150 of 606
Image
Artificial Intelligence and the Future of Blood Cancers webcast
Updated:
In this 2025 webcast, four scientists funded by the LLSC's AI Catalyst Grant talk about their work investigating how AI / machine learning can speed up discovery and detection of blood cancers in their research work. Moderated by Dr. Paul O'Connell, LLSC Research…
Research
Research Champions
Updated:
Research Champions are individuals who made an exceptional contribution to the blood cancer community.
They are people who want to see cures for blood cancers in our lifetime and will stop at nothing to make it happen.
They are people who want to see cures for blood cancers in our lifetime and will stop at nothing to make it happen.
Blood Cancer Day 2025 at University of Toronto's Faculty of Pharmacy
Updated:
The LLSC was invited to present at Blood Cancer Day on Saturday, May 3, 2025 at the University of Toronto Leslie Dan Faculty of Pharmacy.
Events, Partners
One Kilometre at a Time transportation subsidy program
Updated:
The One Kilometre at a Time transportation subsidy from the Leukemia and Lymphoma Society of Canada provides one-time financial support to Canadians with an acute or chronic blood cancer requiring at least 30 km round trip for medical appointment(s) as referred by their…
CLL Live 2025: All things chronic lymphocytic leukemia
Updated:
CLL is one of the most common types of leukemia in adults; CLL Canada holds it free annual conference for patients by patients.
Events, Partners
Image
Understanding multiple myeloma
Updated:
Multiple myeloma, or MM, is a type of blood cancer that starts in the bone marrow. Multiple myeloma affects plasma cells, a type of white blood cell that normally fights infection, turning healthy cells into cancer cells that can damage blood, bones and kidneys.
Myeloma
Canadian Association of Psychosocial Oncology (CAPO) 2025: Care of the soul in cancer
Updated:
LLSC was delighted to have the opportunity to participate again in the annual conference of the Canadian Association of Psychosocial Oncology (CAPO), in Toronto April 2025.
Events, Partners
Addressing the global Pegasys® shortage
Updated:
Following Health Canada’s decision to grant ropeginterferon (BESREMi®) exceptional importation status, some of the provinces and private insurance plans have been starting to cover BESREMi® treatment. Work is continuing in the provinces where there is not yet coverage.
Advocacy, Partners, Myeloproliferative neoplasms
Image
Chronic Lymphocytic Leukemia (CLL) Treatment Discussion Guide
Updated:
Beyond active surveillance (the ‘watch and wait approach’) there are several CLL treatments to consider. Each treatment has different features and side effects. It is important to be comfortable with the CLL treatment you choose.
Leukemia
Managing fatigue and cognitive challenges
Updated:
As a result of your cancer and its treatment, it is likely that you will experience some degree of fatigue. Cancer-related fatigue can be described as feeling very tired and lacking energy in a way that gets in the way of your daily activity or function. If you have problems…
Treatment and side effects